NetworkNewsBreaks – Biocept, Inc. (NASDAQ: BIOC) Move Higher on Heavy Volume Following Patent News
Shares of Biocept (NASDAQ: BIOC) are up more than 6%, continuing a pre-bell rally on news that the commercial provider of liquid biopsy tests designed to ultimately improve the outcomes of cancer patients was awarded U.S. Patent No. 9671407, entitled DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS. The patent – the company’s 20th issued patent in the U.S. and key international territories - covers the broad use of antibodies for the capture of any target of interest on any solid surface from any sample type. Targets of interest include, but are not limited to, circulating tumor cells (CTCs), sub-cellular…







